OpenBilldrug price receipt

NADAC week of 2026-10-14

LACOSAMIDE 100 MG TABLET

For 30 tablets

Pharmacies pay

$5.23 filed

30 × $0.17426 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$11.01 estimated

$5.23 + $0.78 (15%) + $5.00 fee per fill = $11.01

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

LACOSAMIDE 100 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lacosamide.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, NorthStar RxLLC and Unichem Pharmaceuticals (USA), Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 16 NDCs (National Drug Codes); the FDA directory lists 15 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $5.23 for 30 tablets (30 × $0.17426 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 14 labelers

LabelerNDCsPharmacies pay per unit
Breckenridge Pharmaceutical, Inc.2$0.17426 per EA filed
Alembic Pharmaceuticals Inc.1$0.17426 per EA filed
American Health Packaging1$0.17426 per EA filed
Ascend Laboratories, LLC1$0.17426 per EA filed
Aurobindo Pharma Limited1$0.17426 per EA filed
Camber Pharmaceuticals, Inc.1$0.17426 per EA filed
Glenmark Pharmaceuticals Inc. USA1$0.17426 per EA filed
Macleods Pharmaceuticals Limited1$0.17426 per EA filed
Major Pharmaceuticals1$0.17426 per EA filed
NorthStar RxLLC1$0.17426 per EA filed
ScieGen Pharmaceuticals Inc1$0.17426 per EA filed
Sun Pharmaceutical Industries, Inc.1$0.17426 per EA filed
Unichem Pharmaceuticals (USA), Inc.1$0.17426 per EA filed
Westminster Pharmaceuticals, LLC1$0.17426 per EA filed
Not listed as a package in the FDA directory1$0.17426 per EA filed
All 16 NDCs, with labeler and price
  • 00904-7245-68 · Major Pharmaceuticals · $0.17426 per EA · eff. 2026-09-23 filed
  • 16714-0549-01 · NorthStar RxLLC · $0.17426 per EA · eff. 2026-09-23 filed
  • 29300-0365-16 · Unichem Pharmaceuticals (USA), Inc. · $0.17426 per EA · eff. 2026-09-23 filed
  • 31722-0813-60 · Camber Pharmaceuticals, Inc. · $0.17426 per EA · eff. 2026-09-23 filed
  • 33342-0303-09 · Macleods Pharmaceuticals Limited · $0.17426 per EA · eff. 2026-09-23 filed
  • 47335-0922-86 · Sun Pharmaceutical Industries, Inc. · $0.17426 per EA · eff. 2026-09-23 filed
  • 50228-0193-60 · ScieGen Pharmaceuticals Inc · $0.17426 per EA · eff. 2026-09-23 filed
  • 51991-0349-05 · Breckenridge Pharmaceutical, Inc. · $0.17426 per EA · eff. 2026-09-23 filed
  • 51991-0349-06 · Breckenridge Pharmaceutical, Inc. · $0.17426 per EA · eff. 2026-09-23 filed
  • 60687-0687-11 · not listed as a package in the FDA directory · $0.17426 per EA · eff. 2026-09-23 filed
  • 60687-0687-57 · American Health Packaging · $0.17426 per EA · eff. 2026-09-23 filed
  • 62332-0172-60 · Alembic Pharmaceuticals Inc. · $0.17426 per EA · eff. 2026-09-23 filed
  • 65862-0748-60 · Aurobindo Pharma Limited · $0.17426 per EA · eff. 2026-09-23 filed
  • 67877-0734-60 · Ascend Laboratories, LLC · $0.17426 per EA · eff. 2026-09-23 filed
  • 68462-0679-60 · Glenmark Pharmaceuticals Inc. USA · $0.17426 per EA · eff. 2026-09-23 filed
  • 69367-0349-60 · Westminster Pharmaceuticals, LLC · $0.17426 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

14 other products in the NADAC file share the FDA nonproprietary name lacosamide with LACOSAMIDE 100 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
LACOSAMIDE 10 MG/ML SOLUTION
generic · solution
$0.08288 per ML filed
eff. 2026-09-23 to 2026-09-30
We don’t know yet
LACOSAMIDE 50 MG TABLET
generic · tablet, film coated / tablet
$0.11859 per EA filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 100 MG TABLET this page
generic · tablet, film coated / tablet
$0.17426 per EA filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 100 MG/10 ML CUP
generic · solution
$0.08288 per ML filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 150 MG TABLET
generic · tablet, film coated / tablet
$0.22128 per EA filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 200 MG TABLET
generic · tablet, film coated / tablet
$0.24797 per EA filed
eff. 2026-09-23
We don’t know yet
LACOSAMIDE 200 MG/20 ML CUP
generic · solution
$0.08288 per ML filed
eff. 2026-09-23
We don’t know yet
MOTPOLY XR 100 MG CAPSULE
brand · capsule, extended release
$21.43011 per EA filed
eff. 2026-07-01
$20.10931 per EA filed
Part D 2024 average
MOTPOLY XR 150 MG CAPSULE
brand · capsule, extended release
$21.50185 per EA filed
eff. 2026-07-01
$20.10931 per EA filed
Part D 2024 average
MOTPOLY XR 200 MG CAPSULE
brand · capsule, extended release
$21.5109 per EA filed
eff. 2026-07-01
$20.10931 per EA filed
Part D 2024 average
VIMPAT 10 MG/ML SOLUTION
brand · solution
$2.29765 per ML filed
eff. 2026-09-23
We don’t know yet
VIMPAT 50 MG TABLET
brand · tablet, film coated
$11.82165 per EA filed
eff. 2026-09-23
We don’t know yet
VIMPAT 100 MG TABLET
brand · tablet, film coated
$18.53662 per EA filed
eff. 2026-09-23
We don’t know yet
VIMPAT 150 MG TABLET
brand · tablet, film coated
$19.64607 per EA filed
eff. 2026-09-23
We don’t know yet
VIMPAT 200 MG TABLET
brand · tablet, film coated
$19.62683 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.